The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin

We have investigated the effects of charge and lipophilicity on the antibacterial activity of an undecapeptide (FKCRRWQWRMK) derived from the sequence of bovine lactoferricin. We prepared ten analogues that were modified by the incorporation of Ala, Tyr, Trp, Met and Arg residues, which are amino acids known to be important for the antibacterial activity of longer derivatives of lactoferricins. All undecapeptides contained the native Trp residues in positions 6 and 8, and the Arg residues in positions 5 and 9. Generally, the Gram‐positive bacterium Staphylococcus aureus was more susceptible to these undecapeptides than the Gram‐negative bacteria, and a higher antibacterial activity was observed against Escherichia coli than against Pseudomonas aeruginosa. The only exception was the peptide Undeca 9 (RRWYRWAWRMR‐NH2), which was almost equally active against all three test strains, displaying minimal inhibitory concentrations of 10 µg/ml (5.8 µM), 7.5 µg/ml (4.4 µM) and 5 µg/ml (2.9 µM) against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus, respectively. The peptides Undeca 6 (YRAWRWAWRWR‐NH2) and Undeca 7 (YRMWRWAWRWR‐NH2) were the two most active undecapeptides against Staphylococcus aureus, both displaying a minimal inhibitory concentration of 2.5 µg/ml (1.5 µM). The study showed that a level was reached in which undecapeptides having a net charge above +4 and containing three or four Trp residues all displayed a high antibacterial activity. All undecapeptides prepared were essentially non‐haemolytic, but undecapeptides containing more than three Trp residues displayed 50% haemolysis of human red blood cells at concentrations above 400 µg/ml (>230 µM). Copyright © 2002 European Peptide Society and John Wiley & Sons, Ltd.

[1]  D. Hultmark,et al.  Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. , 2005, European journal of biochemistry.

[2]  H. G. Boman,et al.  Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine , 1993, Infection and immunity.

[3]  Ø. Rekdal,et al.  Construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity , 1999 .

[4]  J. Svendsen,et al.  Increased antibacterial activity of 15-residue murine lactoferricin derivatives. , 2001, The journal of peptide research : official journal of the American Peptide Society.

[5]  M. Selsted,et al.  Determination of the disulfide array in the human defensin HNP-2. A covalently cyclized peptide. , 1989, The Journal of biological chemistry.

[6]  S J Ludtke,et al.  Membrane pores induced by magainin. , 1996, Biochemistry.

[7]  R I Lehrer,et al.  Primary structures of three human neutrophil defensins. , 1985, The Journal of clinical investigation.

[8]  E. Krause,et al.  Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. , 1996, Biochemistry.

[9]  S. White,et al.  The preference of tryptophan for membrane interfaces. , 1998, Biochemistry.

[10]  R. B. Merrifield,et al.  Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Ptak,et al.  Penetration of the insect defensin A into phospholipid monolayers and formation of defensin A-lipid complexes. , 1997, Biophysical journal.

[12]  R. Nagaraj,et al.  Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13‐residue peptide indolicidin , 1996, FEBS letters.

[13]  S. Lory,et al.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.

[14]  H. Nikaido Multidrug efflux pumps of gram-negative bacteria , 1996, Journal of bacteriology.

[15]  R. Hancock,et al.  Interaction of the Cyclic Antimicrobial Cationic Peptide Bactenecin with the Outer and Cytoplasmic Membrane* , 1999, The Journal of Biological Chemistry.

[16]  M. Tomita,et al.  A review: The active peptide of lactoferrin , 1994, Acta paediatrica Japonica : Overseas edition.

[17]  M. Selsted,et al.  Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. , 1983, The Journal of biological chemistry.

[18]  K. C. Lee,et al.  Tryptophans in membrane proteins: indole ring orientations and functional implications in the gramicidin channel. , 1993, Biochemistry.

[19]  K. Yamauchi,et al.  Identification of the bactericidal domain of lactoferrin. , 1992, Biochimica et biophysica acta.

[20]  M. Zasloff,et al.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor , 1987 .

[21]  J. Svendsen,et al.  Antibacterial activity of 15-residue lactoferricin derivatives. , 2000, The journal of peptide research : official journal of the American Peptide Society.

[22]  E. Groisman,et al.  How bacteria resist killing by host-defense peptides. , 1994, Trends in microbiology.

[23]  H. Vogel,et al.  Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.

[24]  R. Nagaraj,et al.  Antibacterial and hemolytic activities of single tryptophan analogs of indolicidin. , 2000, Biochemical and biophysical research communications.

[25]  C. B. Park,et al.  Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.

[26]  Randal R Ketchem,et al.  High-resolution conformation of gramicidin A in a lipid bilayer by solid-state NMR. , 1993, Science.

[27]  K. Yamauchi,et al.  Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. , 1991, Journal of dairy science.

[28]  D. King,et al.  A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. , 1990, International journal of peptide and protein research.

[29]  C. Subbalakshmi,et al.  Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.

[30]  M. Selsted,et al.  Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. , 1995, Biochimica et biophysica acta.

[31]  F. Barchiesi,et al.  In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. , 1999, The Journal of antimicrobial chemotherapy.

[32]  H. G. Boman,et al.  Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.

[33]  M. Selsted,et al.  Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. , 1985, The Journal of biological chemistry.

[34]  J. Svendsen,et al.  Bulky aromatic amino acids increase the antibacterial activity of 15‐residue bovine lactoferricin derivatives , 2001, Journal of peptide science : an official publication of the European Peptide Society.

[35]  C. Chang,et al.  The functions of tryptophan residues in membrane proteins. , 1992, Protein engineering.

[36]  Wayne L. Smith,et al.  Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. , 1992, The Journal of biological chemistry.

[37]  Hiroshi Nikaido,et al.  Multidrug resistance mechanisms: drug efflux across two membranes , 2000, Molecular microbiology.

[38]  K. Hahm,et al.  Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. , 2009, International journal of peptide and protein research.